A Free Press Release Service to Submit Your Stories Online

Orbys360 Releases New Report on AI's Impact on Global Capability Centers

Research Initiative Sponsored by FutureFactor360

Bengaluru, India (FreePR.org) -- Orbys360, an AI Knowledge Hub for GCCs, today announced the release of a new research report titled "The GCC Reckoning – How AI Is Rewriting the Economics of Global Capability Centers."

The report examines how Artificial Intelligence is beginning to fundamentally reshape the operating, workforce, and economic foundations of the Global Capability Center (GCC) industry.

For more than two decades, GCCs have largely operated on a model centered around global talent scalability and cognitive labor arbitrage. The report argues that AI is now structurally altering that equation across multiple enterprise functions, including BPM, IT, Engineering, Analytics, Finance, HR, Customer Operations, and ER&D.

Key themes explored include the extent of AI disruption risk across existing GCC roles over the next five years, the emergence of "silent displacement" through hiring freezes, productivity compression, and workforce restructuring, the structural pressures mounting on traditional cost arbitrage models, and the rise of AI-native GCC operating models that evolve GCCs from execution hubs into intelligence, orchestration, and innovation centers.

One of the central observations from the report states:

"The competitive advantage of the GCC model — cheaper human cognition — is precisely what AI automates first, best, and at unlimited scale."

The report positions this shift not purely as a disruption challenge, but as a reinvention opportunity for the GCC ecosystem — built around AI-native operating models, outcome-driven delivery structures, agentic operations, smaller but higher-value teams, enterprise intelligence capabilities, and innovation and transformation ownership.

The report is intended to stimulate broader industry dialogue among Enterprise HQ leaders, GCC leaders, service providers, policymakers, and ecosystem stakeholders on the future direction of the GCC industry in an AI-first world.

The full report is available at orbys360.com/research.

About Orbys360: Orbys360 is the AI Knowledge Hub for Global Capability Centers — bringing together the intelligence, frameworks, tools, and ecosystem that GCCs need to navigate the AI transformation. The platform offers an Enterprise Grade AI Agents Marketplace, an AI Talent Job Board for GCCs, curated daily AI briefings, in-depth research, the AI Agent Thoughtbook, ready-to-use templates and playbooks and a curated provider ecosystem — all purpose-built for enterprise and GCC leaders moving from AI awareness to AI-led operations. Learn more at orbys360.com.

About FutureFactor360: FutureFactor360 is a strategy consulting firm focused on setting up and scaling Global Capability Centers for enterprises worldwide. The firm advises Enterprise HQs and GCC leaders on location strategy, operating models, talent design, governance, and transformation roadmaps across the GCC lifecycle.

Related Links:
orbys360.com

###

Contact Information:
Media Contact team@orbys360.com



Sponsor Message

Canadian pharmacies are a trusted choice for affordable medications, including Lipitor, Crestor, and Nexium. Diabetes patients depend on insulin like Humalog and Lantus, while asthma and COPD sufferers use Advair Diskus and Ventolin inhalers. Mental health conditions are treated with drugs like Zoloft, Prozac, and Abilify, while cardiovascular protection comes from Eliquis, Plavix, and Xarelto. Patients often rely on Celebrex for inflammation and pain relief and Synthroid for managing thyroid issues. Additionally, medications like Viagra and Cialis offer solutions for erectile dysfunction, and drugs like Januvia help manage Type 2 diabetes. For those struggling with narcolepsy or daytime sleepiness, Provigil and Nuvigil are indispensable wakefulness-promoting solutions. Patients in the U.S. benefit from Canadian pharmacies offering medications like Cymbalta for nerve pain and Aricept for Alzheimer's.

SaveRxCanada.to